Literature DB >> 19168708

Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses.

Bihua Bie1, Wei Zhu, Zhizhong Z Pan.   

Abstract

The rewarding effect of opioids, the driving force for compulsive behaviors of opioid abuse and addiction, is primarily mediated by the mu-opioid receptor. However, the role of the delta-opioid receptor (DOR) in opioid reward and addiction is still poorly understood. The recently discovered adaptive DOR property of exocytotic translocation in sensory neurons after chronic opioid exposure provides a new avenue of conceptual thoughts to exploring the DOR function in this psychoneurological disease. In this study, we investigated potential adaptive function of DOR in neurons of the central nucleus of the amygdala (CeA), a forebrain structure increasingly recognized for mediating stimulus reward learning in drug addiction. Using whole-cell recordings in CeA slices, we found that in rats displaying morphine-induced behavior of conditioned place preference, a behavioral measure of drug reward, the overall synaptic strength of glutamate synapses in CeA neurons was significantly enhanced. The selective DOR agonist [D-Pen(2),D-Pen(5)]-enkephalin, having no apparent effect on glutamatergic excitatory postsynaptic current (EPSC) in neurons from control rats, produced a significant, dose-dependent inhibition of the synaptic current in neurons from those morphine-treated rats. Detailed analyses of EPSC properties revealed that DOR activation inhibited the EPSC by reducing presynaptic release of glutamate, indicating functional DOR emerging on presynaptic glutamate terminals. The morphine treatment also significantly increased DOR proteins in CeA preparations of synaptosomes. These findings provide functional evidence for an adaptive modulation by presynaptic DOR of a key synaptic activity altered by morphine, thus implying likely important involvement of DOR in opioid reward and addiction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168708      PMCID: PMC2670596          DOI: 10.1124/jpet.108.148908

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  37 in total

1.  The amygdala modulates prefrontal cortex activity relative to conditioned fear.

Authors:  R Garcia; R M Vouimba; M Baudry; R F Thompson
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

Review 2.  Cellular and synaptic adaptations mediating opioid dependence.

Authors:  J T Williams; M J Christie; O Manzoni
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

Review 3.  Opioid receptors.

Authors:  Maria Waldhoer; Selena E Bartlett; Jennifer L Whistler
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 4.  Mu opioid receptor: a gateway to drug addiction.

Authors:  Candice Contet; Brigitte L Kieffer; Katia Befort
Journal:  Curr Opin Neurobiol       Date:  2004-06       Impact factor: 6.627

5.  Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons.

Authors:  W Zhu; Z Z Pan
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 6.  Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.

Authors:  Clifford J Woolf; Maliha Hashmi
Journal:  Curr Opin Investig Drugs       Date:  2004-01

7.  A rapid Percoll gradient procedure for preparation of synaptosomes.

Authors:  Peter R Dunkley; Paula E Jarvie; Phillip J Robinson
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

8.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.

Authors:  H W Matthes; R Maldonado; F Simonin; O Valverde; S Slowe; I Kitchen; K Befort; A Dierich; M Le Meur; P Dollé; E Tzavara; J Hanoune; B P Roques; B L Kieffer
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

9.  Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.

Authors:  S Sbrenna; M Marti; M Morari; G Calo'; R Guerrini; L Beani; C Bianchi
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

10.  Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord.

Authors:  Anne Morinville; Catherine M Cahill; Haneen Aibak; Vladimir V Rymar; Amynah Pradhan; Cyrla Hoffert; Françoise Mennicken; Thomas Stroh; Abbas F Sadikot; Dajan O'Donnell; Paul B S Clarke; Brian Collier; James L Henry; Jean-Pierre Vincent; Alain Beaudet
Journal:  J Neurosci       Date:  2004-06-16       Impact factor: 6.167

View more
  29 in total

1.  Signaling cascades for δ-opioid receptor-mediated inhibition of GABA synaptic transmission and behavioral antinociception.

Authors:  Zhi Zhang; Zhizhong Z Pan
Journal:  Mol Pharmacol       Date:  2011-12-05       Impact factor: 4.436

Review 2.  Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors.

Authors:  Stephen M Johnson; Sara M F Turner
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

3.  Persistent pain facilitates response to morphine reward by downregulation of central amygdala GABAergic function.

Authors:  Zhi Zhang; Wenjuan Tao; Yuan-Yuan Hou; Wei Wang; Yun-Gang Lu; Zhizhong Z Pan
Journal:  Neuropsychopharmacology       Date:  2014-04-01       Impact factor: 7.853

4.  Verifying of participation of nitric oxide in morphine place conditioning in the rat medial septum using nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d).

Authors:  Manizheh Karami; Mohsen Karimian Azimi; Mohammad Reza Zarrindast; Zeinab Khalaji
Journal:  Iran Biomed J       Date:  2010-10

5.  Amyloid fibrils induce dysfunction of hippocampal glutamatergic silent synapses.

Authors:  Bihua Bie; Jiang Wu; Joseph F Foss; Mohamed Naguib
Journal:  Hippocampus       Date:  2018-05-07       Impact factor: 3.899

6.  Upregulation of nerve growth factor in central amygdala increases sensitivity to opioid reward.

Authors:  Bihua Bie; Yan Wang; You-Qing Cai; Zhi Zhang; Yuan-Yuan Hou; Zhizhong Z Pan
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

7.  A novel opioid receptor-mediated enhancement of GABAA receptor function induced by stress in ventral tegmental area neurons.

Authors:  Elyssa B Margolis; Jennifer M Mitchell; Gregory O Hjelmstad; Howard L Fields
Journal:  J Physiol       Date:  2011-06-20       Impact factor: 5.182

Review 8.  Amygdala pain mechanisms.

Authors:  Volker Neugebauer
Journal:  Handb Exp Pharmacol       Date:  2015

9.  Reversal effect of intra-central amygdala microinjection of L-arginine on place aversion induced by naloxone in morphine conditioned rats.

Authors:  Sara Karimi; Manizheh Karami; Hedayat Sahraei; Mahnaz Rahimpour
Journal:  Iran Biomed J       Date:  2011

10.  Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn.

Authors:  Paul J Wrigley; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  Mol Pain       Date:  2010-10-26       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.